News und Analysen
![Geratherm: Explosion nach Corona-News!](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Geratherm: Explosion nach Corona-News!
Die explosivsten Wertsteigerungen verzeichnen in Corona-Zeiten Aktien von Unternehmen, deren Präparate oder Produkte zur Eindämmung oder Bekämpfung des COVID-19-Virus dienen. Die heutige News von Ge
![Premier Inc. Survey: More Than Two-Thirds of Senior Living Facilities Say They Can’t Access Personal Protective Equipment Needed for COVID-19 Containment Plans](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Premier Inc. Survey: More Than Two-Thirds of Senior Living Facilities Say They Can’t Access Personal Protective Equipment Needed for COVID-19 Containment Plans
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results finding that more than two-thirds of senior living facilities in the United States cannot obtain
![Agilent Introduces CrossLab Connect Services for Lab-wide Asset Monitoring](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Agilent Introduces CrossLab Connect Services for Lab-wide Asset Monitoring
Agilent Technologies Inc. (NYSE: A) announced today an extension to its digital lab capabilities with Agilent CrossLab Asset Monitoring, an advanced service for laboratories seeking increased
![Chemed Corporation’s Board of Directors Authorizes an Additional $250 Million for Stock Repurchase](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Chemed Corporation’s Board of Directors Authorizes an Additional $250 Million for Stock Repurchase
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $250 million for stock repurchase under Chemed’s existing share repurchase program
![Agilent Receives Two Scientists’ Choice Awards](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Agilent Receives Two Scientists’ Choice Awards
Agilent Technologies Inc. (NYSE: A) today announced that two of the company’s instruments have received Scientists’ Choice awards. The Agilent 8890 GC system won for Best New Separations Product
![Hanger Reports Fourth Quarter 2019 Results and Provides 2020 Outlook](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Hanger Reports Fourth Quarter 2019 Results and Provides 2020 Outlook
Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the fourth quarter and year ended
![Symmetry, das LivaNova VNS Therapy-System für schwer zu behandelnde Depressionen, erhält CE-Prüfzeichen](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Symmetry, das LivaNova VNS Therapy-System für schwer zu behandelnde Depressionen, erhält CE-Prüfzeichen
LivaNova PLC (NASDAQ:LIVN), ein marktführendes medizintechnisches Innovationsunternehmen, gab heute bekannt, dass sein System Vagus Nerve Stimulation Therapy® (VNS Therapy) Symmetry™ die
![Humana Takes Steps to Care for Members in Response to Coronavirus](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Humana Takes Steps to Care for Members in Response to Coronavirus
Humana Inc. (NYSE: HUM) announced today several actions in response to the increased spread of the coronavirus (COVID-19).
“As we navigate the spread of the coronavirus, our top priority is the
![American Renal Associates Holdings, Inc. Announces Fourth Quarter 2019 Earnings Release Date and Conference Call](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
American Renal Associates Holdings, Inc. Announces Fourth Quarter 2019 Earnings Release Date and Conference Call
American Renal Associates Holdings, Inc. (NYSE: ARA), a leading kidney care and dialysis provider focused on partnering with local nephrologists, announced today that it will hold its fourth
![LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Vagus Nerve Stimulation Therapy® (VNS Therapy) System, Symmetry™, earned CE Mark approval
![NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the pricing of $200 million aggregate principal amount of 2.625%
![NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that it intends to offer, subject to market conditions and other
![Veeva Announces Fiscal 2020 Fourth Quarter and Fiscal Year 2020 Results](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Veeva Announces Fiscal 2020 Fourth Quarter and Fiscal Year 2020 Results
Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal fourth quarter ended January 31, 2020
![Mauna Kea Technologies Receives FDA Clearance And CE Marking For Its Next-Generation Cellvizio® Platform](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Mauna Kea Technologies Receives FDA Clearance And CE Marking For Its Next-Generation Cellvizio® Platform
Regulatory News:
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE)
![Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research
Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.
The new Agilent
![Premier Inc. Survey Finds 86 Percent of Health Systems Are Concerned About Personal Protective Equipment Shortages Due to Coronavirus](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Premier Inc. Survey Finds 86 Percent of Health Systems Are Concerned About Personal Protective Equipment Shortages Due to Coronavirus
Premier Inc. (NASDAQ: PINC) today released survey results finding that 86 percent of U.S. hospitals and health systems are concerned about their supply of face masks and other personal protective
![Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions
Agilent Technologies Inc. (NYSE: A) and Visiopharm today announced that they have entered a co-marketing agreement. The announcement is happening at the USCAP 109th Annual Meeting being held
![Waters Drives Materials Sciences Innovation Forward at Pittcon 2020 with New Instrument Introductions](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Waters Drives Materials Sciences Innovation Forward at Pittcon 2020 with New Instrument Introductions
Waters Corporation (NYSE:WAT) today introduced new products that bring greater productivity and efficiency to materials science research. The new Discovery™ X3 Differential Scanning Calorimeter
![Agilent Technologies Announces Webcasts for Investment Community](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Agilent Technologies Announces Webcasts for Investment Community
Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community.
40th Annual Cowen And Company Healthcare Conference
Tuesday, March 3, 2020 at 10:00 a.m
![Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.
Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit relating to BGI’s “CoolMPS” sequencing products. The complaint was filed against BGI Genomics Co., Ltd
![LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a research collaboration with Verily, an Alphabet company, to capture measures of depression
![NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today reported financial results for the fourth quarter and year ended December 31
![Healthcare Improvement Company Premier Inc. to Present at Raymond James 41st Annual Institutional Investors Conference in Orlando on March 3](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Healthcare Improvement Company Premier Inc. to Present at Raymond James 41st Annual Institutional Investors Conference in Orlando on March 3
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that its CEO, Susan DeVore, and Chief Administrative and Financial Officer, Craig McKasson, will present at
![Aledade and Humana Announce Broadened Collaboration, Signing Value-Based Agreement for Humana Medicare Members in North Carolina](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Aledade and Humana Announce Broadened Collaboration, Signing Value-Based Agreement for Humana Medicare Members in North Carolina
Aledade, Inc. and leading health and well-being company Humana Inc. (NYSE: HUM) today announced an agreement to expand the availability of value-based care for Humana Medicare Advantage members in
![Veeva’s Antitrust Lawsuit Against IQVIA Advances With Widespread Industry Support](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Veeva’s Antitrust Lawsuit Against IQVIA Advances With Widespread Industry Support
Veeva Systems (NYSE: VEEV) today announced it is gaining widespread customer support for its antitrust lawsuit against IQVIA (NYSE: IQV). Six of the largest global pharmaceutical companies were